CTT Pharmaceutical Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTTH research report →
Price Chart
About the company
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems.
- CEO
- Ryan Khouri
- IPO
- 1997
- Employees
- 1
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on CTTH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.38M
- P/E
- -43.54
- PEG
- 1.45
- P/S
- 0.00
- P/B
- 129.80
- EV/EBITDA
- -27.71
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -324.21%
- ROIC
- -284.29%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-6,432-0.5%
- Op Income
- $-126,770
- Net Income
- $-155,907+25.8%
- EPS
- $-0.00+30.8%
- OCF Growth
- -122.8%
- FCF Growth
- -122.8%
- 52W High
- $0.10
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.07
- Beta
- 0.72
- RSI (14)
- 56
- Avg Volume
- 36.76K
No earnings-call transcripts are available for CTTH yet.
- Free Float
- 95.9%
- Shares Outstanding
- 59.72M
- Float Shares
- 57.25M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 6, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 3,700 |
| Sep 22, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 10,100 |
| Sep 28, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 3,400 |
| Sep 22, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 10,100 |
| Sep 16, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 10,900 |
| Sep 10, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 3,500 |
| Sep 4, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 9,800 |
| Sep 2, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 3,000 |
| Aug 31, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 3,500 |
| Aug 24, 26 | CTT PHARMACEUTICAL HOLDINGS, INC. | buy | 2,100 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CTTH coverage
Recent articles, reports, and earnings notes.
No research on CTTH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CTTH report →CTT Pharma Corporate Updates
thenewswire.com · Sep 16
CTT Pharma Files a Patent Continuation with the U.S. Patent Office
thenewswire.com · Aug 18
CTT Pharma Corporate Updates
thenewswire.com · Aug 12
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology
thenewswire.com · Aug 10
CTT Pharma Receives SEC Approval
thenewswire.com · Aug 5
CTT Pharma Signs LOI with European Company
thenewswire.com · May 14
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
accessnewswire.com · Dec 30
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
accessnewswire.com · Dec 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.